-+ 0.00%
-+ 0.00%
-+ 0.00%

United Therapeutics CEO Martine A. Rothblatt disposes of USD 3.94 million in common shares

PUBT·09/10/2026 20:32:01
Listen to the news
United Therapeutics CEO Martine A. Rothblatt disposes of USD 3.94 million in common shares
  • United Therapeutics Chairperson and CEO Martine A. Rothblatt reported a 9,500-share common stock acquisition via option exercise on Sept. 9, 2026.
  • Exercise price USD 117.76; shares held indirectly by a trust.
  • The trust also sold 8,500 common shares on Sept. 9 at weighted-average prices from USD 493.81 to USD 509.
  • Trust holdings ended at 324,443 shares following the reported transactions.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. United Therapeutics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001106578-26-000138), on September 10, 2026, and is solely responsible for the information contained therein.